Shares of multibagger small-cap stock Blue Cloud Softech Solutions Ltd rose 6 per cent on Monday, December 9, after the company received a $15 million order to supply advanced MDM solutions for medical devices.
Blue Cloud Softech Solutions Share price closed 5.92 percent higher Rs 140.35 on Monday as compared to the previous market close. 132.50. Blue Cloud Softech Solutions Shares hit intra-day high 145.75. Shares rose in the last few minutes of trading after the order win was announced.
On BSE, the total traded volume was over 6.3 lakh shares, significantly higher than the two-week average volume of 1.13 lakh shares. The market capitalization of the company was 3,061.61 crore.
small hat Stock hits its 52-week high 261 on BSE on July 29, 2024, while hitting a 52-week low According to exchange data, it reached 46.08 on March 20.
Blue Cloud Softech Solutions The shares have given multibagger returns in the last one year, with a rise of 116 per cent during this period. Meanwhile, on a year-to-date (YTD) basis, the stock is up 135 percent. Over a four-year-long period, the stock has risen nearly 1,100 percent to the current level of 12 in December 2020 140.35 each.
From January 1 to December 9, shares have increased 140 percent year-on-year. Shares of Blue Cloud Softtech have increased by 116 percent. Rs 140.35 in current market session compared to year-on-year Last year 64.97.
contract details
The Hyderabad-based company announced that it has signed a $15 million contract to deliver its Blueport – a mobile device management (MDM) platform specifically designed to optimize the management of mobile devices. biomedical equipment.
“We are excited to secure the MDM order along with secure OS development for medical devices and bring our innovative solutions to the healthcare sector,” Janaki Yarlagadda, chairperson of Blue Cloud Softech Solutions Ltd, said in an exchange filing.
The Blueport platform streamlines device management through remote configuration, centralized store Tracking, and timely firmware updates. According to the press release, Blueport also enhances workflow by enabling efficient app delivery, automated user provisioning, and remote troubleshooting.
The system enhances biomedical device management by leveraging advanced technologies that ensure robust security with strong encryption, remote management capabilities, and granular access controls. “In addition, this solution meets stringent regulatory requirements, including HIPAA compliance,” according to the release.
“BluePort is designed to empower organizations to effectively manage their biomedical devices, ultimately improving patient outcomes,” Yarlagadda said.
Disclaimer: The views and recommendations expressed in this article are those of the individual analysts. These do not represent the views of the Mint. We recommend investors to check with certified experts before taking any investment decision.
